| Primary |
| Hypertension |
22.2% |
| Hyperlipidaemia |
20.0% |
| Diabetes Mellitus |
6.7% |
| Essential Hypertension |
6.7% |
| Gastritis |
5.6% |
| Constipation |
5.0% |
| Rheumatoid Arthritis |
5.0% |
| Hyperuricaemia |
3.9% |
| Endoscopy |
3.3% |
| Acute Sinusitis |
2.2% |
| Dyslipidaemia |
2.2% |
| Gastric Ulcer |
2.2% |
| Hypercholesterolaemia |
2.2% |
| Nasopharyngitis |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Cerebral Infarction |
1.7% |
| Enterocolitis |
1.7% |
| Gastroduodenal Ulcer |
1.7% |
| Reflux Oesophagitis |
1.7% |
| Retinal Depigmentation |
1.7% |
|
| Rhabdomyolysis |
28.9% |
| Platelet Count Decreased |
8.9% |
| Pneumonia |
8.9% |
| Pneumonia Aspiration |
6.7% |
| Blood Lactate Dehydrogenase Increased |
4.4% |
| C-reactive Protein Increased |
4.4% |
| Death |
4.4% |
| Interstitial Lung Disease |
4.4% |
| Liver Disorder |
4.4% |
| Blood Creatine Phosphokinase Increased |
2.2% |
| Cerebral Haemorrhage |
2.2% |
| Colon Cancer |
2.2% |
| Dry Mouth |
2.2% |
| Leukopenia |
2.2% |
| Malaise |
2.2% |
| Muscular Weakness |
2.2% |
| Oedema Peripheral |
2.2% |
| Pyrexia |
2.2% |
| Renal Failure Acute |
2.2% |
| Skin Lesion Excision |
2.2% |
|
| Secondary |
| Drug Use For Unknown Indication |
29.0% |
| Hypertension |
20.2% |
| Hyperlipidaemia |
6.2% |
| Product Used For Unknown Indication |
5.5% |
| Diabetes Mellitus |
4.8% |
| Multiple Myeloma |
4.4% |
| Myocardial Infarction |
4.0% |
| Angina Pectoris |
2.9% |
| Glomerulonephritis Chronic |
2.6% |
| Infection |
2.6% |
| Hypercholesterolaemia |
2.2% |
| Atrial Fibrillation |
2.0% |
| Reflux Oesophagitis |
2.0% |
| Antiplatelet Therapy |
1.8% |
| Cardiac Failure |
1.8% |
| Constipation |
1.8% |
| Prophylaxis |
1.8% |
| Asthma |
1.5% |
| Benign Prostatic Hyperplasia |
1.5% |
| Gastritis |
1.5% |
|
| Rhabdomyolysis |
14.3% |
| Hepatic Function Abnormal |
13.1% |
| Monoplegia |
9.5% |
| Renal Impairment |
8.3% |
| Prostate Cancer |
7.1% |
| Blood Creatine Phosphokinase Increased |
4.8% |
| Liver Disorder |
4.8% |
| Myocardial Infarction |
4.8% |
| Respiratory Failure |
4.8% |
| Hepatitis |
3.6% |
| Interstitial Lung Disease |
3.6% |
| Blood Lactate Dehydrogenase Increased |
2.4% |
| Capillary Disorder |
2.4% |
| Cardiac Failure |
2.4% |
| Gamma-glutamyltransferase Increased |
2.4% |
| Jaundice |
2.4% |
| Liver Function Test Abnormal |
2.4% |
| Loss Of Consciousness |
2.4% |
| Platelet Count Decreased |
2.4% |
| Pneumonitis |
2.4% |
|
| Concomitant |
| Hypertension |
23.8% |
| Hyperlipidaemia |
11.2% |
| Drug Use For Unknown Indication |
8.3% |
| Product Used For Unknown Indication |
7.6% |
| Prophylaxis |
6.2% |
| Diabetes Mellitus |
6.1% |
| Rheumatoid Arthritis |
5.6% |
| Insomnia |
4.3% |
| Constipation |
3.8% |
| Gastritis |
3.1% |
| Osteoporosis |
2.7% |
| Angina Pectoris |
2.7% |
| Type 2 Diabetes Mellitus |
2.6% |
| Cardiac Failure |
2.1% |
| Hypercholesterolaemia |
2.1% |
| Gastric Ulcer |
1.9% |
| Herpes Zoster |
1.6% |
| Cerebral Infarction |
1.5% |
| Psoriasis |
1.4% |
| Parkinson's Disease |
1.4% |
|
| Hepatic Function Abnormal |
10.0% |
| Vomiting |
8.6% |
| Interstitial Lung Disease |
8.4% |
| Pyrexia |
7.4% |
| White Blood Cell Count Increased |
6.3% |
| Pneumonia |
6.0% |
| Renal Impairment |
6.0% |
| Thrombocytopenia |
5.1% |
| Cerebral Infarction |
4.6% |
| Renal Failure Acute |
4.6% |
| Platelet Count Decreased |
3.7% |
| Rhabdomyolysis |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| Myocardial Infarction |
3.5% |
| Sepsis |
3.5% |
| Liver Disorder |
3.2% |
| Sudden Death |
3.2% |
| Death |
2.8% |
| Hypoglycaemia |
2.8% |
| Ventricular Extrasystoles |
2.8% |
|
| Interacting |
| Cardiac Failure |
14.0% |
| Hypertension |
14.0% |
| Angina Pectoris |
9.3% |
| Hyperlipidaemia |
9.3% |
| Atrial Fibrillation |
7.0% |
| Myocardial Ischaemia |
7.0% |
| Prophylaxis |
7.0% |
| Reflux Oesophagitis |
7.0% |
| Stent Placement |
7.0% |
| Histiocytosis Haematophagic |
4.7% |
| Percutaneous Coronary Intervention |
4.7% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Immunodeficiency |
2.3% |
| Muscle Tightness |
2.3% |
| Vitamin Supplementation |
2.3% |
|
| Rhabdomyolysis |
75.0% |
| Renal Impairment |
25.0% |
|
